Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neuronetics Inc (NQ: STIM )

1.820 -0.090 (-4.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,589
Open 1.930
Bid (Size) 1.810 (1)
Ask (Size) 2.120 (11)
Prev. Close 1.910
Today's Range 1.820 - 1.970
52wk Range 1.030 - 5.070
Shares Outstanding 29,997,563
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 
From Neuronetics
Via GlobeNewswire
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga

Performance

YTD
-33.82%
-33.82%
1 Month
-28.06%
-28.06%
3 Month
-57.38%
-57.38%
6 Month
-25.87%
-25.87%
1 Year
-14.55%
-14.55%

More News

Read More
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
From Neuronetics
Via GlobeNewswire
Earnings Outlook For Neuronetics
Via Benzinga
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
Via Benzinga
Exposures Fossil Fuels
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
From Neuronetics
Via GlobeNewswire
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
From Neuronetics
Via GlobeNewswire
Top 5 Health Care Stocks That May Plunge In March
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
From Neuronetics
Via GlobeNewswire
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
From Neuronetics
Via GlobeNewswire
Earnings Scheduled For March 5, 2024
Via Benzinga
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
From Neuronetics
Via GlobeNewswire
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
From Neuronetics
Via GlobeNewswire
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
From Neuronetics
Via GlobeNewswire
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
From Neuronetics
Via GlobeNewswire
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
From Neuronetics
Via GlobeNewswire
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
From Neuronetics
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.